← All trials
NCT07121023
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 26, 2025
- Primary completion
- Dec 27, 2025
- Completion date
- Dec 27, 2025
- First posted
- Aug 13, 2025
- Last posted
- Aug 13, 2025
- Enrollment
- 32
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Beijing Tide Pharmaceutical Co., LtdLead sponsor
- Peking UniversityCollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.